Mach-1 Financial Group’s AstraZeneca AZN Stock Holding History

Mach-1 Financial Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-117	Closed	-$12K	–	185
2022 Q3	$12K	Hold	117	–	–	0.01%	201
2022 Q2	$15K	Hold	117	–	–	0.01%	196
2022 Q1	$15K	Hold	117	–	–	0.01%	101
2021 Q4	$13K	Buy	+117	New	+$13.8K	0.01%	104
2021 Q3	–	Sell	-117	Closed	-$14K	–	26
2021 Q2	$14K	Hold	117	–	–	0.01%	74
2021 Q1	$11K	Hold	117	–	–	0.01%	110
2020 Q4	$11K	Buy	+117	New	+$12.4K	0.01%	102

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mach-1 Financial Group's AZN Position: Q4 2022 in Review

Mach-1 Financial Group sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 117 shares — an estimated $12K sold.

Mach-1 Financial Group first reported a position in AZN in Q4 2020 and held it in 7 quarters. The position peaked at $15K in Q2 2022. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

Mach-1 Financial Group reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
Mach-1 Financial Group sold 117 AstraZeneca shares in Q4 2022, an estimated $12K.
Mach-1 Financial Group first reported a position in AstraZeneca in Q4 2020 and held it in 7 quarters.
Mach-1 Financial Group's AstraZeneca position peaked at $15K in Q2 2022.
1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Mach-1 Financial Group's 13F filing for Q4 2022, filed 2 Feb 2023.